综合计算方法揭示了克桑衍生物对马尔堡病毒核囊的潜在抑制作用
Sai Kiran1, Saleem Javid2, Somashekhar M Metri3
1Department of Pharmacology, KLE College of Pharmacy, Bengaluru-560010, KLE Academy of Higher Education and Research, 590010 Belagavi, India.
Virusdisease
|November 24, 2025
概括
马格尼弗林是一种来自Swertia chirata的化合物,在治疗马堡病毒 (MARV) 感染方面表现有前途. 它有效地抑制病毒的VP35蛋白,提供了潜在的新治疗途径.
科学领域:
- 病毒学 病毒学
- 药用化学 医学化学
- 计算生物学 计算生物学
背景情况:
- 由于其高死亡率和有限的治疗选择,马堡病毒 (MARV) 构成了全球重大健康风险.
- VP35蛋白质是MARV复制必不可少的关键病毒成分,使其成为抗病毒药物开发的关键目标.
研究的目的:
- 通过使用来自Swertia chirata的Xanthone衍生物来识别马尔堡病毒VP35RNA结合域的潜在抑制剂.
- 通过计算方法评估已识别的化合物的结合亲和力,稳定性和药理动力学特性.
主要方法:
- 基于结构的虚拟查和分子对接被用来评估针对MARV VP35.35的选择植物化合物的抑制潜力.
- 分子动力学 (MD) 模拟,主要组件分析 (PCA),自由能量景观 (FEL) 映射和MM/GBSA计算被用于分析Magniferin-VP35复合物的稳定性和结合相互作用.
主要成果:
- 马格尼菲林与Remdesivir (-5.0 kcal/mol) 相比,对MARV VP35 RNA结合域表现出更高的结合亲和力 (-7.0 kcal/mol).
- 所有选的化合物都遵守了利宾斯基的五项规则,显示了有利的ADME和毒性概况.
- MD模拟和随后的分析证实了Magniferin-VP35复合物的热力学稳定性和形状灵活性,由强大的范德瓦尔斯和库伦比相互作用驱动.
结论:
- 马格尼菲林显示出作为一种主要化合物的显著潜力,用于开发针对马尔堡病毒的新疗法.
- 这项研究强调了计算方法在识别有希望的天然产品衍生抗病毒药物的有效性.
相关概念视频
Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


